David Domzalski - Jun 30, 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Stock symbol
VYNE
Transactions as of
Jun 30, 2023
Transactions value $
-$4,022
Form type
4
Date filed
7/5/2023, 04:30 PM
Previous filing
Jun 2, 2023
Next filing
Oct 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$4.02K -981 -1.84% $4.10 52.4K Jun 30, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.